Francesca Salvianti, Cinzia Pupilli and Pamela Pinzani
Circulating Tumor Cells (CTCs) are considered a liquid biopsy of solid tumors, reflecting the disease complexity at any stage of cancer progression. CTCs, in fact, represent a surrogate material of the tumor which can be obtained by a minimally invasive blood draw and used for disease monitoring and orienting therapeutic decisions, but their detection and characterization are technically challenging.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 